-

AB Value-Radoff Group Announces Acceptance of Latest Settlement Terms Proposed by Rocky Mountain Chocolate Factory

Looks Forward to Promptly Receiving a Standard Cooperation Agreement That Provides for the Addition of a New, Highly Qualified Director and Customary Terms

WESTFIELD, N.J.--(BUSINESS WIRE)--AB Value Management LLC and Bradley L. Radoff (together with their affiliates, the "AB Value-Radoff Group" or "we"), who own approximately 17.6% of the outstanding shares of Rocky Mountain Chocolate Factory, Inc. (NASDAQ: RMCF) ("Rocky Mountain" or the "Company"), today issued the following statement:

“Earlier this week, our representative informed Rocky Mountain’s legal counsel that we agree to all of the Company’s latest publicly disclosed settlement terms. The framework we have agreed to provides for the addition of our nominee to the Board of Directors and other customary terms. By compromising with Rocky Mountain, we hope to facilitate improved corporate governance and enhanced value creation over the long-term. We intend to engage in good faith to expeditiously finalize a cooperation agreement that can benefit all of the Company’s stockholders.”

Contacts

Saratoga Proxy Consulting
John Ferguson / Joe Mills, 212-257-1311
info@saratogaproxy.com

Longacre Square Partners
Greg Marose / Bela Kirpalani, 646-386-0091
gmarose@longacresquare.com / bkirpalani@longacresquare.com

AB Value Management LLC and Bradley L. Radoff

NASDAQ:RMCF

Release Versions

Contacts

Saratoga Proxy Consulting
John Ferguson / Joe Mills, 212-257-1311
info@saratogaproxy.com

Longacre Square Partners
Greg Marose / Bela Kirpalani, 646-386-0091
gmarose@longacresquare.com / bkirpalani@longacresquare.com

More News From AB Value Management LLC and Bradley L. Radoff

Bradley L. Radoff Announces Vote AGAINST the Reelection of Marston’s PLC’s Non-Executive Directors

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who collectively with his affiliates owns approximately 3% of the outstanding common shares of Marston’s PLC (LSE: MARS) ("Marston’s" or the "Company"), today issued the following open letter to shareholders regarding Mr. Radoff’s decision to vote against the reelection of the Company’s five non-executive members of the Board of Directors (the “Board”) at the upcoming Annual General Meeting (“AGM”): Chair Ken Lever, Octavia Morley, Rachel Osborne, Br...

Concerned Shareholder Bradley L. Radoff Urges Quipt Home Medical’s Board of Directors to Pursue a Value-Maximizing Sale

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who collectively with his affiliates owns approximately 4.9% of the outstanding common shares of Quipt Home Medical Corp. (NYSE: QIPT) ("Quipt" or the "Company"), today issued the following statement regarding the manner in which the Company’s Board of Directors (the “Board”) has failed to capitalize on apparent acquirer interest: “The Board has spent years destroying its credibility by presiding over poor execution and significant shareholder value...

The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group”), who collectively own approximately 5.4% of the outstanding stock of Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) (“Atea” or the “Company”), today announced that they have nominated three highly qualified director candidates – Howard H. Berman, James Flynn and Mr. Torok – for election to the Company’s Board of Directors (the “Board”) at the 2025 Annual Meeting of Stockh...
Back to Newsroom